Pharmaceutical quality: an urgent and unresolved issue

Michael Seear | 01 Jun 2012
The Lancet Infectious Diseases
Selling of substandard and counterfeit drugs has been an issue ever since an early herbalist's assistant noted that one pile of dry herbs looked much like another. The only changes have been the increasing expertise and extent of the problem. The international response to counterfeit drugs began with a 1988 World Health Assembly resolution that called for WHO to help prevent and detect the spread of so-called substandard/spurious/falsely-labelled/falsified/counterfeit drugs.

Full article available with registration at